{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:59:56Z","timestamp":1792839596432,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T00:00:00Z","timestamp":1636848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T00:00:00Z","timestamp":1636848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12072-021-10264-w","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T01:02:16Z","timestamp":1636851736000},"page":"434-451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trial"],"prefix":"10.1007","volume":"17","clinical-trial-number":[{"clinical-trial-number":"nct03566914","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Rakesh Kumar","family":"Jagdish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Kamaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saggere Muralikrishna","family":"Shasthry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"Benjamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakhi","family":"Maiwall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur","family":"Jindal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayaraghavan","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Bhardwaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3448-8334","authenticated-orcid":false,"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv K.","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,14]]},"reference":[{"key":"10264_CR1","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0140-6736(12)60520-0","volume":"381","author":"R Shamloul","year":"2013","unstructured":"Shamloul R, Ghanem H. Erectile dysfunction. Lancet 2013;381:153\u2013165","journal-title":"Lancet"},{"issue":"3","key":"10264_CR2","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jceh.2018.07.007","volume":"9","author":"J Thakur","year":"2019","unstructured":"Thakur J, Rathi S, Grover S, Chopra M, Agrawal S, Taneja S, et al. Tadalafil, a phosphodiesterase-5 inhibitor, improves erectile dysfunction in patients with liver cirrhosis. J Clin Exp Hepatol 2019;9(3):312\u2013317","journal-title":"J Clin Exp Hepatol"},{"issue":"6","key":"10264_CR3","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.dld.2018.10.015","volume":"51","author":"S Maimone","year":"2019","unstructured":"Maimone S, Saffioti F, Oliva G, Di Benedetto A, Alibrandi A, Filomia R, et al. Erectile dysfunction in compensated liver cirrhosis. Dig Liver Dis 2019;51(6):843\u2013849","journal-title":"Dig Liver Dis"},{"issue":"8","key":"10264_CR4","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1111\/liv.13704","volume":"38","author":"R Paternostro","year":"2018","unstructured":"Paternostro R, Heinisch BB, Reiberger T, Mandorfer M, Schwarzer R, Seeland B, et al. Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension. Liver Int 2018;38(8):1427\u20131436","journal-title":"Liver Int"},{"issue":"6","key":"10264_CR5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/hep.1840040622","volume":"4","author":"CM Cornely","year":"1984","unstructured":"Cornely CM, Schade RR, Van Thiel DH, Gavaler JS. Chronic advanced liver disease and impotence: cause and effect? Hepatology 1984;4(6):1227\u20131230","journal-title":"Hepatology"},{"issue":"9","key":"10264_CR6","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1007\/s00535-005-1634-8","volume":"40","author":"K Toda","year":"2005","unstructured":"Toda K, Miwa Y, Kuriyama S, Fukushima H, Shiraki M, Murakami N, et al. Erectile dysfunction in patients with chronic viral liver disease: its relevance to protein malnutrition. J Gastroenterol 2005;40(9):894\u2013900","journal-title":"J Gastroenterol"},{"issue":"2","key":"10264_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/j.1600-0676.1985.tb00221.x","volume":"5","author":"SB Jensen","year":"1985","unstructured":"Jensen SB, Gluud C. Sexual dysfunction in men with alcoholic liver cirrhosis. A comparative study. Liver 1985;5(2):94\u2013100","journal-title":"Liver"},{"issue":"6","key":"10264_CR8","first-page":"531","volume":"38","author":"YJ Wang","year":"1991","unstructured":"Wang YJ, Wu JC, Lee SD, Tsai YT, Lo KJ. Gonadal dysfunction and changes in sex hormones in postnecrotic cirrhotic men: a matched study with alcoholic cirrhotic men. Hepatogastroenterology 1991;38(6):531\u2013534","journal-title":"Hepatogastroenterology"},{"issue":"4","key":"10264_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/sj.ijir.3901316","volume":"17","author":"I Simsek","year":"2005","unstructured":"Simsek I, Aslan G, Akarsu M, Koseoglu H, Esen A. Assessment of sexual functions in patients with chronic liver disease. Int J Impot Res 2005;17(4):343\u2013345","journal-title":"Int J Impot Res"},{"issue":"5","key":"10264_CR10","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1111\/j.1743-6109.2008.01169.x","volume":"6","author":"E Huyghe","year":"2009","unstructured":"Huyghe E, Kamar N, Wagner F, Capietto AH, El-Kahwaji L, Muscari F, et al. Erectile dysfunction in end-stage liver disease men. J Sex Med 2009;6(5):1395\u20131401","journal-title":"J Sex Med"},{"key":"10264_CR11","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1111\/j.1572-0241.2006.00544.x","volume":"101","author":"A Danoff","year":"2006","unstructured":"Danoff A, Khan O, Wan DW, et al. Sexual dysfunction is highly prevalent among men with chronic hepatitis C virus infection and negatively impacts health-related quality of life. Am J Gastroenterol 2006;101:1235\u20131243","journal-title":"Am J Gastroenterol"},{"issue":"1 Pt 1","key":"10264_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1161\/01.HYP.29.1.8","volume":"29","author":"RH Grimm Jr","year":"1997","unstructured":"Grimm RH Jr, Grandits GA, Prineas RJ, McDonald RH, Lewis CE, Flack JM, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997;29(1 Pt 1):8\u201314","journal-title":"Hypertension"},{"key":"10264_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1046\/j.1525-1497.1998.00050.x","volume":"13","author":"MS Litwin","year":"1998","unstructured":"Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med 1998;13:159\u2013166","journal-title":"J Gen Intern Med"},{"key":"10264_CR14","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.jsxm.2018.05.016","volume":"15","author":"Q Liu","year":"2018","unstructured":"Liu Q, Zhang Y, Wang J, et al. Erectile dysfunction and depression: a systematic review and meta-analysis. J Sex Med 2018;15:1073\u20131082","journal-title":"J Sex Med"},{"key":"10264_CR15","first-page":"170","volume":"120","author":"G Marchesini","year":"2001","unstructured":"Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Hepatology 2001;120:170\u2013178","journal-title":"Hepatology"},{"issue":"21","key":"10264_CR16","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1021\/jm030056e","volume":"46","author":"A Daugan","year":"2003","unstructured":"Daugan A, Grondin P, Ruault C, et al. The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,11,11a-tetrahydro-1H-imidazo( 1\u2019,5\u2019: 1,6)pyrido(3,4-b)indole-1,3(2H)-dione analogues. J Med Chem 2003;46(21):4525\u20134532","journal-title":"J Med Chem"},{"key":"10264_CR17","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1177\/0091270005276847","volume":"45","author":"M Gupta","year":"2005","unstructured":"Gupta M, Kovar A, Meibohm B. The clinical pharmacokinetics of phosphodiesterase-5 inhibitors for erectile dysfunction. J Clin Pharmacol 2005;45:987\u20131003","journal-title":"J Clin Pharmacol"},{"key":"10264_CR18","unstructured":"CIALIS (tadalafil) tablets Label\u2013FDA. 2021. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs. Accessed 2 Jan 2018"},{"key":"10264_CR19","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1111\/j.1572-0241.2002.05876.x","volume":"97","author":"C Tzathas","year":"2002","unstructured":"Tzathas C, Christidou A, Ladas SD. Sildenafil (viagra) is a risk factor for acute variceal bleeding. Am J Gastroenterol 2002;97:1856","journal-title":"Am J Gastroenterol"},{"key":"10264_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.cursur.2004.06.019","volume":"62","author":"DS Finley","year":"2005","unstructured":"Finley DS, Lugo B, Ridgway J, Teng W, Imagawa DK. Fatal variceal rupture after sildenafil use: report of a case. Curr Surg 2005;62:55\u201356","journal-title":"Curr Surg"},{"issue":"6","key":"10264_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.cgh.2010.01.017","volume":"8","author":"P Tandon","year":"2010","unstructured":"Tandon P, Inayat I, Tal M, Spector M, Shea M, Groszmann RJ, et al. Sildenafil has no effect on portal pressure but lowers arterial pressure in patients with compensated cirrhosis. Clin Gastroenterol Hepatol 2010;8(6):546\u2013549","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"40","key":"10264_CR22","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.3748\/wjg.14.6208","volume":"14","author":"JO Clemmesen","year":"2008","unstructured":"Clemmesen JO, Giraldi A, Ott P, Dalhoff K, Hansen BA, Larsen FS. Sildenafil does not influence hepatic venous pressure gradient in patients with cirrhosis. World J Gastroenterol 2008;14(40):6208\u20136212","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10264_CR23","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1872-034X.2008.00388.x","volume":"38","author":"KC Lee","year":"2008","unstructured":"Lee KC, Yang YY, Wang YW, Hou MC, Lee FY, Lin HC, et al. Acute administration of sildenafil enhances hepatic cyclic guanosine monophosphate production and reduces hepatic sinusoid resistance in cirrhotic patients. Hepatol Res 2008;38(12):1186\u20131193","journal-title":"Hepatol Res"},{"issue":"1","key":"10264_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1365-2036.2006.02735.x","volume":"23","author":"P Deibert","year":"2006","unstructured":"Deibert P, Schumacher YO, Ruecker G, Opitz OG, Blum HE, R\u00f6ssle M, et al. Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver \u2013 results of a pilot study. Aliment Pharmacol Ther 2006;23(1):121\u2013128","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10264_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.dld.2014.10.018","volume":"47","author":"W Kreisel","year":"2015","unstructured":"Kreisel W, Deibert P, Kupcinskas L, Sumskiene J, Appenrodt B, Roth S, et al. The phosphodiesterase-5-inhibitor udenafil lowers portal pressure in compensated preascitic liver cirrhosis. A dose-finding phase-II-study. Dig Liver Dis 2015;47(2):144\u2013150","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10264_CR26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3748\/wjg.v24.i3.438","volume":"24","author":"P Deibert","year":"2018","unstructured":"Deibert P, Lazaro A, Stankovic Z, Schaffner D, R\u00f6ssle M, Kreisel W. Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: a case report with 8 years follow-up. World J Gastroenterol 2018;24(3):438\u2013444","journal-title":"World J Gastroenterol"},{"issue":"13","key":"10264_CR27","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1111\/bph.14205","volume":"175","author":"KE Andersson","year":"2018","unstructured":"Andersson KE. PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery. Br J Pharmacol 2018;175(13):2554\u20132565","journal-title":"Br J Pharmacol"},{"key":"10264_CR28","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0090-4295(99)00099-0","volume":"54","author":"JC Cappelleri","year":"1999","unstructured":"Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999;54:346","journal-title":"Urology"},{"issue":"4","key":"10264_CR29","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L","volume":"1","author":"DA Karnofsky","year":"1948","unstructured":"Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma\u2013with particular reference to bronchogenic carcinoma. Cancer 1948;1(4):634\u2013656","journal-title":"Cancer"},{"key":"10264_CR30","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","volume":"49","author":"RC Rosen","year":"1997","unstructured":"Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile function. Urology 1997;49:822\u2013830","journal-title":"Urology"},{"issue":"1","key":"10264_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.urology.2011.01.019","volume":"78","author":"PN Dogra","year":"2011","unstructured":"Dogra PN, Saini AK, Seth A. Erectile dysfunction after anterior urethroplasty: a prospective analysis of incidence and probability of recovery\u2013single-center experience. Urology 2011;78(1):78\u201381","journal-title":"Urology"},{"issue":"1","key":"10264_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/ijir.2009.35","volume":"22","author":"O Mohamed","year":"2010","unstructured":"Mohamed O, Freundlich RE, Dakik HK, Grober ED, Najari B, Lipshultz LI, et al. The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism. Int J Impot Res 2010;22(1):20\u201324","journal-title":"Int J Impot Res"},{"issue":"10","key":"10264_CR33","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166(10):1092\u20131097","journal-title":"Arch Intern Med"},{"issue":"9","key":"10264_CR34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16(9):606\u2013613","journal-title":"J Gen Intern Med"},{"key":"10264_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware","year":"1992","unstructured":"Ware JE, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473\u2013483","journal-title":"Med Care"},{"issue":"1","key":"10264_CR36","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","volume":"70","author":"European Association for the Study of the Liver","year":"2019","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines on nutrition in chronic liver disease. J Hepatol 2019;70(1):172\u2013193","journal-title":"J Hepatol"},{"issue":"3","key":"10264_CR37","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1097\/MEG.0000000000000274","volume":"27","author":"M Giusto","year":"2015","unstructured":"Giusto M, Lattanzi B, Albanese C, Galtieri A, Farcomeni A, Giannelli V, et al. Sarcopenia in liver cirrhosis: the role of computed tomography scan for the assessment of muscle mass compared with dual-energy X-ray absorptiometry and anthropometry. Eur J Gastroenterol Hepatol 2015;27(3):328\u2013334","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10264_CR38","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","volume":"10","author":"R Jaeschke","year":"1989","unstructured":"Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407\u2013415","journal-title":"Control Clin Trials"},{"key":"10264_CR39","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.eururo.2011.07.053","volume":"60","author":"RC Rosen","year":"2011","unstructured":"Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the International Index of Erectile Function scale. Eur Urol 2011;60:1010\u20131016","journal-title":"Eur Urol"},{"issue":"12","key":"10264_CR40","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/diacare.25.12.2159","volume":"25","author":"TI de S\u00e1enz","year":"2002","unstructured":"de S\u00e1enz TI, Anglin G, Knight JR, Emmick JT. Effects\u00a0of\u00a0tadalafil\u00a0on\u00a0erectile dysfunction\u00a0in\u00a0men\u00a0with\u00a0diabetes. Diabetes Care 2002;25(12):2159\u20132164","journal-title":"Diabetes Care"},{"issue":"23","key":"10264_CR41","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020546","volume":"99","author":"KS Kim","year":"2020","unstructured":"Kim KS, Jeong TY, Moon HS. Effect of daily tadalafil on reported outcomes in patients with erectile dysfunction and depressive symptoms: STROBE, a case-control study. Medicine (Baltimore) 2020;99(23): e20546","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10264_CR42","doi-asserted-by":"publisher","first-page":"501","DOI":"10.21037\/tau.2019.08.24","volume":"8","author":"JB Choi","year":"2019","unstructured":"Choi JB, Cho KJ, Kim JC, Pae CU, Koh JS. An open-label, single-arm pilot study to evaluate the efficacy of daily low dose tadalafil on depression in patients with erectile dysfunction. Transl Androl Urol 2019;8(5):501\u2013506","journal-title":"Transl Androl Urol"},{"key":"10264_CR43","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fpsyt.2017.00308","volume":"8","author":"T Kishi","year":"2018","unstructured":"Kishi T, Yoshimura R, Ikuta T, et al. Brain-derived neurotrophic factor and major depressive disorder: evidence from meta-analyses. Front Psychiatry 2018;8:308","journal-title":"Front Psychiatry"},{"key":"10264_CR44","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E. Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol 2007;81:294\u2013330","journal-title":"Prog Neurobiol"},{"key":"10264_CR45","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11011-014-9533-4","volume":"29","author":"C Wang","year":"2014","unstructured":"Wang C, Zhang J, Lu Y, et al. Antidepressant-like effects of the phosphodiesterase-4 inhibitor etazolate and phosphodiesterase-5 inhibitor sildenafil via cyclic AMP or cyclic GMP signaling in mice. Metab Brain Dis 2014;29:673\u2013682","journal-title":"Metab Brain Dis"},{"key":"10264_CR46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ijir.2013.38","volume":"26","author":"YS Shim","year":"2014","unstructured":"Shim YS, Pae CU, Cho KJ, et al. Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study. Int J Impot Res 2014;26:76\u201380","journal-title":"Int J Impot Res"},{"issue":"51","key":"10264_CR47","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013827","volume":"97","author":"JG Lee","year":"2018","unstructured":"Lee JG, Kim BD, Han CH, Lee KK, Yum KS. Evaluation of the effectiveness and safety of a daily dose of 5 mg of tadalafil, over an 8-week period, for improving quality of life among Korean men with andropause symptoms, including erectile dysfunction: a pilot study. Medicine (Baltimore) 2018;97(51): e13827","journal-title":"Medicine (Baltimore)"},{"key":"10264_CR48","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/j.1743-6109.2009.01222.x","volume":"6","author":"E Rubio-Aurioles","year":"2009","unstructured":"Rubio-Aurioles E, Kim ED, Rosen RC, et al. Impact on erectile function and sexual quality of life of couples: a double-blind, randomized, placebo-controlled trial of tadalafil taken once daily. J Sex Med 2009;6:1314\u20131323","journal-title":"J Sex Med"},{"issue":"4","key":"10264_CR49","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1023\/A:1012270220064","volume":"10","author":"F Giuliano","year":"2001","unstructured":"Giuliano F, Pe\u00f1a BM, Mishra A, Smith MD. Efficacy results and quality-of-life measures in men receiving sildenafil citrate for the treatment of erectile dysfunction. Qual Life Res 2001;10(4):359\u2013369","journal-title":"Qual Life Res"},{"key":"10264_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/sj.bjp.0703831","volume":"132","author":"LJ Sampson","year":"2001","unstructured":"Sampson LJ, Hinton JM, Garland CJ. Evidence for expression and function of phosphodiesterase type 5 (PDE-V) in rat resistance arteries. Br J Pharmacol 2001;132:13\u201317","journal-title":"Br J Pharmacol"},{"key":"10264_CR51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1478-3231.2004.00892.x","volume":"24","author":"I Colle","year":"2004","unstructured":"Colle I, De Vriese AS, Van Vlierberghe H, Lameire NH, DeVos M. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients. Liver Int 2004;24:63\u201368","journal-title":"Liver Int"},{"key":"10264_CR52","doi-asserted-by":"publisher","first-page":"3C","DOI":"10.1016\/S0002-9149(99)00042-9","volume":"83","author":"RM Wallis","year":"1999","unstructured":"Wallis RM, Corbin JD, Francis SH, Ellis P. Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro. Am J Cardiol 1999;83:3C-12C","journal-title":"Am J Cardiol"},{"key":"10264_CR53","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1183\/09031936.06.00030206","volume":"28","author":"F Reichenberger","year":"2006","unstructured":"Reichenberger F, Voswinckel R, Steveling E, Enke B, Kreckel A, Olschewski H, et al. Sildenafil treatment for portopulmonary hypertension. Eur Respir J 2006;28:563\u2013567","journal-title":"Eur Respir J"},{"key":"10264_CR54","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/lt.21479","volume":"15","author":"AR Hemnes","year":"2009","unstructured":"Hemnes AR, Robbins IM. Sildenafil monotherapy in portopulmonary hypertension can facilitate liver transplantation. Liver Transpl 2009;15:15\u201319","journal-title":"Liver Transpl"},{"key":"10264_CR55","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/lt.21533","volume":"15","author":"MS Gough","year":"2009","unstructured":"Gough MS, White RJ. Sildenafil therapy is associated with improved hemodynamics in liver transplantation candidates with pulmonary arterial hypertension. Liver Transpl 2009;15:30\u201336","journal-title":"Liver Transpl"},{"key":"10264_CR56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1155\/2015\/810376","volume":"22","author":"JH Fisher","year":"2015","unstructured":"Fisher JH, Johnson SR, Chau C, Kron AT, Granton JT. Effectiveness of phosphodiesterase-5 inhibitor therapy for portopulmonary hypertension. Can Respir J 2015;22:42\u201346","journal-title":"Can Respir J"},{"key":"10264_CR57","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1183\/09031936.00110006","volume":"29","author":"P Deibert","year":"2007","unstructured":"Deibert P, Bremer H, Roessle M, Kurz-Schmieg AK, Kreisel W. PDE-5 inhibitors lower portal and pulmonary pressure in portopulmonary hypertension. Eur Respir J 2007;29:220\u2013221","journal-title":"Eur Respir J"},{"key":"10264_CR58","first-page":"050","volume":"52","author":"M Jevnikar","year":"2018","unstructured":"Jevnikar M, Ebstein N, Jais X, Boucly A, Montani D, Humbert M, et al. Efficacy and safety of tadalafil in portopulmonary hypertension. Eur Respir J 2018;52:050","journal-title":"Eur Respir J"},{"issue":"39","key":"10264_CR59","doi-asserted-by":"publisher","first-page":"5009","DOI":"10.3748\/wjg.v16.i39.5009","volume":"16","author":"GN Kalambokis","year":"2010","unstructured":"Kalambokis GN, Kosta P, Pappas K, Tsianos EV. Haemodynamic and renal effects of tadalafil in patients with cirrhosis. World J Gastroenterol 2010;16(39):5009\u20135010","journal-title":"World J Gastroenterol"},{"issue":"2","key":"10264_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/hep.20565","volume":"41","author":"S Erceg","year":"2005","unstructured":"Erceg S, Monfort P, Hern\u00e1ndez-Viadel M, Rodrigo R, Montoliu C, Felipo V. Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology 2005;41(2):299\u2013306","journal-title":"Hepatology"},{"issue":"5","key":"10264_CR61","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.eururo.2007.09.046","volume":"53","author":"WJ Hellstrom","year":"2008","unstructured":"Hellstrom WJ, Gittelman M, Jarow J, Steidle C, McMurray J, Talley D, et al. An evaluation of semen characteristics in men 45 years of age or older after daily dosing with tadalafil 20mg: results of a multicenter, randomized, double-blind, placebo-controlled, 9-month study. Eur Urol 2008;53(5):1058\u20131065","journal-title":"Eur Urol"},{"issue":"6","key":"10264_CR62","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1002\/hep.30359","volume":"69","author":"SF Neong","year":"2019","unstructured":"Neong SF, Billington EO, Congly SE. Sexual dysfunction and sex hormone abnormalities in patients with cirrhosis: review of pathogenesis and management. Hepatology 2019;69(6):2683\u20132695","journal-title":"Hepatology"},{"issue":"4","key":"10264_CR63","first-page":"159","volume":"7","author":"SL Washington 3rd","year":"2010","unstructured":"Washington SL 3rd, Shindel AW. A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy. Drug Des Dev Ther 2010;7(4):159\u2013171","journal-title":"Drug Des Dev Ther"},{"issue":"5","key":"10264_CR64","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3904\/kjim.2019.148","volume":"35","author":"H Park","year":"2020","unstructured":"Park H, Jang IY, Han M, Lee H, Jung HW, Lee E, et al. Sarcopenia is associated with severe erectile dysfunction in older adults: a population-based cohort study. Korean J Intern Med 2020;35(5):1245\u20131253","journal-title":"Korean J Intern Med"},{"key":"10264_CR65","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/13685538.2018.1441276","volume":"22","author":"S Ucak","year":"2019","unstructured":"Ucak S, Sivritepe R, Kara O, et al. Association between sarcopenia and erectile dysfunction in males with type II diabetes mellitus. Aging Male 2019;22:20\u201327","journal-title":"Aging Male"},{"key":"10264_CR66","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/S0016-5085(88)80081-7","volume":"95","author":"C Gluud","year":"1988","unstructured":"Gluud C, Wantzin P, Eriksen J. No effect of oral testosterone treatment on sexual dysfunction in alcoholic cirrhotic men. Gastroenterology 1988;95:1582\u20131587","journal-title":"Gastroenterology"},{"key":"10264_CR67","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jhep.2016.06.007","volume":"65","author":"M Sinclair","year":"2016","unstructured":"Sinclair M, Grossmann M, Hoermann R, Angus PW, Gow PJ. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: a randomised controlled trial. J Hepatol 2016;65:906\u2013913","journal-title":"J Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10264-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-021-10264-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-021-10264-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T16:10:19Z","timestamp":1699805419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-021-10264-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,14]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10264"],"URL":"https:\/\/doi.org\/10.1007\/s12072-021-10264-w","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,14]]},"assertion":[{"value":"7 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Rakesh Kumar Jagdish, Ahmed Kamaal, Saggere Muralikrishna Shasthry, Jaya Benjamin, Rakhi Maiwall, Ankur Jindal, Ashok Choudhary, Vijayaraghavan Rajan, Vinod Arora, Ankit Bhardwaj, Guresh Kumar, Manoj Kumar, Shiv K. Sarin have no conflicts of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Institutional Review Board (IRB) of the Institute of Liver and Biliary Sciences, New Delhi, India, where the study was conducted (Institutional ethical committee number: IEC\/2018\/60\/MA04and the trial is registered at ClinicalTrials.gov with identifier number: NCT03566914.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and registration"}},{"value":"Informed consent was taken from the participants and the work was done in accordance with the declaration of Helsinki.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent to participate and publish"}}]}}